๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Biochemical and immunohistochemical estrogen and progesterone receptors in adenomatous hyperplasia and endometrial carcinoma: Correlations with stage and other clinicopathologic features

โœ Scribed by H.C.J. Nyholm; A.L. Nielsen; J. Lyndrup; P. Norup; S.M. Thorpe

Book ID
118891745
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
262 KB
Volume
42
Category
Article
ISSN
0020-7292

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Steroid receptor coactivator AIB1 in end
Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: correlation with clinicopathologic parameters and biomarkers
โœ Balmer, Nicole N; Richer, Jennifer K; Spoelstra, Nicole S; Torkko, Kathleen C; L ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 424 KB

Members of the p160 steroid receptor cofactor family, including AIB1 (Amplified in Breast Cancer 1) (also known as SRC-3/RAC3/ACTR/pCIP/TRAM-1), are of interest in endometrial carcinoma as they affect the function of estrogen (ER) and progesterone receptors (PR). Since it is feasible that alteration

Immunohistochemical determination of est
Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and dna flow cytometry
โœ Heikki J. Helin; Markku J. Helle; Olli-Pekka Kallioniemi; Jorma J. Isola ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 695 KB ๐Ÿ‘ 1 views

Human breast carcinomas (n = 232) were evaluated for estrogen and progesterone receptors (ER, PR) by immunohistochemical study and by cytosol steroid-binding assay (n = 185). The staining was scored (histoscore) by estimates of relative nuclear staining intensity and the percentage of positively sta

Expression of ps2 protein in endometrial
Expression of ps2 protein in endometrial carcinomas: Correlation with clinicopathologic features and sex steroid receptor status
โœ Masafumi Koshiyama; Masumi Yoshida; Mitsunaga Konishi; Maki Takemura; Yasuichiro ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 529 KB

Using immunohistochemistry, we examined pS2 expression in 64 samples of endometrial carcinoma, 11 samples of endometrial hyperplasia and 15 samples of normal endometrium, and compared them with clinicopathological data, estrogen receptor (ER) expression and progesterone receptor (PR) expression. Of